Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 219 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10019, Peoria, IL — Peoria, Illinois (4.3 mi)
· Sponsor: Colorado Prevention Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi)
· Sponsor: Daiichi Sankyo
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
OSF HealthCare Cancer Institute — Peoria, Illinois (4.3 mi)
· Sponsor: Proton Collaborative Group
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
Normal and Diseased Tissue and Body Fluids Samples
N/A
Observational 100,000 participants sought
Children's Hospital of Illinois at OSF-Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
OSF St. Francis Medical Center /ID# 274752 — Peoria, Illinois (4.3 mi)
· Sponsor: AbbVie
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Phase 3
Interventional 500 participants sought
The University of Illinois at Chicago/OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Jerry Zimmerman
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
OSF Saint Francis Medical Center- — Peoria, Illinois (4.3 mi)
· Sponsor: PPD Development, LP
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Other
N/A
Interventional 97 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Wake Forest University Health Sciences
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
OSF HealthCare Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: DiaMedica Therapeutics Inc
Pounce™ Thrombectomy System Retrospective Registry
Peripheral Arterial Disease, Acute Limb Ischemia
N/A
Observational 500 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: SurModics, Inc.
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 310 participants sought
Osf Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: BeOne Medicines
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Illinois CancerCare, P.C. — Peoria, Illinois (4.3 mi)
· Sponsor: Pfizer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Illinois Eye Center - Peoria Location /ID# 277127 — Peoria, Illinois (4.3 mi)
· Sponsor: AbbVie
Flow Detection in Open and Closed Shunt Valve Periods
Hydrocephalus
N/A
Interventional 55 participants sought
OSF Healthcare — Peoria, Illinois (4.3 mi)
· Sponsor: Rhaeos, Inc.
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Congenital Antithrombin Deficiency
Phase 3
Interventional 38 participants sought
Bleeding and Clotting Disorders Institute — Peoria, Illinois (4.3 mi)
· Sponsor: Octapharma